Aurora Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 31-12-2024
- Paid Up Capital ₹ 3.62 M
as on 31-12-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.00 Cr
as on 31-12-2024
- Revenue 68.93%
(FY 2022)
- Profit 283.91%
(FY 2022)
- Ebitda 43.67%
(FY 2022)
- Net Worth 41.76%
(FY 2022)
- Total Assets 9.67%
(FY 2022)
About Aurora Nutraceuticals
The Corporate was formerly known as Mercy Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.62 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anil Arora and Rishabh Arora serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC120803
- Company No.
120803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Aurora Nutraceuticals Private Limited offer?
Aurora Nutraceuticals Private Limited offers a wide range of products and services, including Skin Care, Sanitizers & Handwash.
Who are the key members and board of directors at Aurora Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Arora  | Director | 10-Apr-2018 | Current |
| Rishabh Arora | Director | 02-Jan-2023 | Current |
Financial Performance of Aurora Nutraceuticals.
Aurora Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.93% increase. The company also saw a substantial improvement in profitability, with a 283.91% increase in profit. The company's net worth Soared by an impressive increase of 41.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurora Nutraceuticals?
In 2021, Aurora Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A N Pharmaceuticals Private LimitedActive 24 years 1 monthAnil Arora and Rishabh Arora are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ing Vysya Bank Limited Creation Date: 26 Oct 2012 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Aurora Nutraceuticals?
Aurora Nutraceuticals has a workforce of 50 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurora Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurora Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
